Patient-specific Modelling Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
Cardiovascular disease is undoubtedly the biggest killer in the developed world and accounts for 30% of all deaths in Australia; killing one Australian every twelve minutes. My research group and I, combine medical imaging with biomedical engineering to perform patient-specific modelling. For example, we can predict the likelihood that aneurysm will rupture or the way blood flows through the aorta. My goal is to make these modelling tools accurate and robust enough to be used in the clinic.
This research will develop cutting-edge computational tools and statistical methods to analyse, model and visualise the way in which the human brain is interconnected. The tools developed will be used to identify biological markers in the brain’s network of axonal circuitry (the connectome) that are valuable for diagnosis and prognosis of psychiatric disorders. This research will bring to fruition the exciting potential of connectomics in neuroscience and psychiatry.
Understanding The Impact Of Age And Chronic Infection On The T Cell Recognition And Control Of Infectious Disease
Funder
National Health and Medical Research Council
Funding Amount
$506,151.00
Summary
The effectiveness of immune responses to infectious diseases and vaccines declines during prolonged infection and is compromised in the very young and elderly. This research aims to better understand the compromise of the immune recognition and control of chronic infections and age-related defects in immunity. Such understanding is crucial to the development of strategies to improve the outcome of infections across the lifespan and the design of vaccines for chronic infections such as HIV.
Understanding And Preventing Population-level Harm From Alcohol
Funder
National Health and Medical Research Council
Funding Amount
$425,048.00
Summary
This project will support Dr Livingston's world-leading work to better understand the reasons that alcohol consumption and related-harm changes at the population level. It will also support projects that will directly assess the impact of changes to alcohol policies in Australia and the development of policy simulation models, to provide critical evidence and ensure well-informed policy decisions can be made to reduce alcohol-related harm.
Evaluation Of New Screening Strategies For Prevention Of Cancer
Funder
National Health and Medical Research Council
Funding Amount
$251,144.00
Summary
Governments, clinicians and consumers have a need for accurate and up-to-date information about the cost-effectiveness, benefits and harms of cancer screening. This project will evaluate whether further changes to cervical screening will be needed after the release of next generation HPV vaccines, whether new screening programs should be implemented for lung cancer and Lynch syndrome, the potential role of new technologies for bowel screening, and whether prostate testing can be improved.
Targeting Bacterial ÏsuperbugsÍ By Innovative Combination Dosing Strategies And New Antibiotics
Funder
National Health and Medical Research Council
Funding Amount
$463,650.00
Summary
This research project will elucidate the mechanistic basis to optimally combine available beta-lactam antibiotics to prevent resistance of gram-negative bacterial ïsuperbugsÍ. These mechanistic insights will be utilised to develop novel antibiotics that are active against these multidrug-resistant bacteria. The interdisciplinary project will substantially contribute to solving the global crisis due to multidrug-resistant bacteria and inform the design of effective new antibiotics.
Using Mathematical Models Of Infection To Inform The Design And Analysis Of Epidemiologic Studies.
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Childhood immunisation has been enormously successful at preventing death and disease. Not all vaccines provide life-long protection, however, and booster doses may be required for older children or even adults. Deciding when and how often doses are required depends on how a particular infection is spread within families and the community both before and after vaccine use. We want to understand more about this process and its implications for the ongoing effectiveness of vaccine programs.